ClinicalTrials.govpublic full text
A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
autoimmune hepatitis, immunoproteasome inhibition, selective proteasome inhibition, disease flare, liver enzymes, alt (alanine aminotransferase), ast (aspartate aminotransferase), glucocorticoids, steroids, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854702
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.